
Reddys Therapeutics Private Limited
About Reddys Therapeutics Private Limited
Data last updated:
Reddys Therapeutics Private Limited is a private limited company based in Nellore, Andhra Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 21 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2016PTC104315.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Rebala Rupakala and Mohan Reddy Enaganuri.
Its last annual general meeting (AGM) was held on 04 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at G – 3 Sri Balaji Avanue Opp – St. Josef Church Kavery Nagar Kondayapalem Gate, Nellore, Andhra Pradesh, India – 524003.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.89 Lakh. For the same year it recorded a net loss of ₹2,132 (net margin -0.4%) and EBITDA of -₹1,812 (EBITDA margin -0.3%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Reddys Therapeutics Private Limited's registered office is in Nellore, Andhra Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressG – 3 Sri Balaji Avanue Opp – St. Josef Church Kavery Nagar Kondayapalem Gate, Nellore, Andhra Pradesh, India – 524003
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Reddys Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reddys Therapeutics Private Limited
FY 2023 filings availableReddys Therapeutics Private Limited reported revenue of ₹5.89 Lakh for FY 2022.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹5.89 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,812 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,132 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.3% | ||||
| Net Profit Margin | -0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Reddys Therapeutics Private Limited, buy the company report.
Board of directors of Reddys Therapeutics Private Limited
Reddys Therapeutics has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rebala Rupakala Also directs: Hatri Pharma Private Limited, Emr Laboratories Private Limited | Director | 21 Oct 2016 | 10 Years 1 Months | Current |
| Mohan Reddy Enaganuri | Director | 21 Oct 2016 | 10 Years 1 Months | Current |
| Mohan Sai Sundar Reddy Devarapalli | Director | 20 Mar 2025 | 1 Years 8 Months | Current |
Shareholding
The shareholding of Reddys Therapeutics Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Reddys Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Reddys Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reddys Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reddys Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reddys Therapeutics Private Limited has 3 board changes on record since 2016: 3 appointments. The latest: Mohan Sai Sundar Reddy Devarapalli was appointed as Director on 20 Mar 2025.
Frequently asked questions
Reddys Therapeutics is an active private limited company based in Nellore, Andhra Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 21 October 2016 (10+ years old) and is registered under CIN U24290AP2016PTC104315.
Reddys Therapeutics has 3 current directors:
- Rebala Rupakala - Director
- Mohan Reddy Enaganuri - Director
- Mohan Sai Sundar Reddy Devarapalli - Director
The latest financial statements of Reddys Therapeutics on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 04 September 2023. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Reddys Therapeutics is U24290AP2016PTC104315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reddys Therapeutics was incorporated on 21 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Vijayawada.
Mohan Sai Sundar Reddy Devarapalli was appointed as Director on 20 Mar 2025. Mohan Reddy Enaganuri was appointed as Director on 21 Oct 2016. Rebala Rupakala was appointed as Director on 21 Oct 2016.
The registered office of Reddys Therapeutics is at G – 3 Sri Balaji Avanue Opp – St. Josef Church Kavery Nagar Kondayapalem Gate, Nellore, Andhra Pradesh, India – 524003.
Reddys Therapeutics operates in the healthcare industry, in the preventive health services segment.
The compliance status of Reddys Therapeutics is compliant as of 22 July 2026. The company is actively filing with the Registrar of Companies.
Reddys Therapeutics can be reached at its registered office: G – 3 Sri Balaji Avanue Opp – St. Josef Church Kavery Nagar Kondayapalem Gate, Nellore, Andhra Pradesh, India – 524003.

